92 related articles for article (PubMed ID: 9084457)
1. Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4.
Madsen H; Rasmussen BB; Brøsen K
Clin Pharmacol Ther; 1997 Mar; 61(3):319-24. PubMed ID: 9084457
[TBL] [Abstract][Full Text] [Related]
2. Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients.
Koyama E; Tanaka T; Chiba K; Kawakatsu S; Morinobu S; Totsuka S; Ishizaki T
J Clin Psychopharmacol; 1996 Aug; 16(4):286-93. PubMed ID: 8835703
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy.
Morinobu S; Tanaka T; Kawakatsu S; Totsuka S; Koyama E; Chiba K; Ishizaki T; Kubota T
Psychiatry Clin Neurosci; 1997 Aug; 51(4):253-7. PubMed ID: 9316174
[TBL] [Abstract][Full Text] [Related]
4. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
Damkier P; Brøsen K
Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
[TBL] [Abstract][Full Text] [Related]
5. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
6. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.
Madsen H; Nielsen KK; Brøsen K
Br J Clin Pharmacol; 1995 Apr; 39(4):433-9. PubMed ID: 7640151
[TBL] [Abstract][Full Text] [Related]
7. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
[TBL] [Abstract][Full Text] [Related]
8. Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.
Eap CB; Bender S; Gastpar M; Fischer W; Haarmann C; Powell K; Jonzier-Perey M; Cochard N; Baumann P
Ther Drug Monit; 2000 Apr; 22(2):209-14. PubMed ID: 10774635
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test.
Eap CB; Bondolfi G; Zullino D; Bryois C; Fuciec M; Savary L; Jonzier-Perey M; Baumann P
Ther Drug Monit; 2001 Jun; 23(3):228-31. PubMed ID: 11360030
[TBL] [Abstract][Full Text] [Related]
10. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
[TBL] [Abstract][Full Text] [Related]
11. Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivo.
Larsen JT; Brøsen K
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):141-8. PubMed ID: 16128907
[TBL] [Abstract][Full Text] [Related]
12. Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.
Kilicarslan T; Haining RL; Rettie AE; Busto U; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):460-5. PubMed ID: 11259331
[TBL] [Abstract][Full Text] [Related]
13. Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study.
Gram LF; Guentert TW; Grange S; Vistisen K; Brøsen K
Clin Pharmacol Ther; 1995 Jun; 57(6):670-7. PubMed ID: 7781267
[TBL] [Abstract][Full Text] [Related]
14. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes.
Kobayashi K; Chiba K; Yagi T; Shimada N; Taniguchi T; Horie T; Tani M; Yamamoto T; Ishizaki T; Kuroiwa Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):927-33. PubMed ID: 9023308
[TBL] [Abstract][Full Text] [Related]
15. Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1'-hydroxylation.
Emoto C; Iwasaki K
Xenobiotica; 2007 Jun; 37(6):592-603. PubMed ID: 17614006
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y
Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390
[TBL] [Abstract][Full Text] [Related]
17. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
Stresser DM; Kupfer D
Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
[TBL] [Abstract][Full Text] [Related]
18. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
[TBL] [Abstract][Full Text] [Related]
19. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
20. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine.
Skjelbo E; Brøsen K; Hallas J; Gram LF
Clin Pharmacol Ther; 1991 Jan; 49(1):18-23. PubMed ID: 1988236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
